Skip to content

King Pharmaceuticals KG Legacy Reinsurance — Gross premiums written

Similar metrics at other companies

Everest Group logo
EGLegacy — Premiums Written, Gross
$135M-80.3%
Everest Group logo
EGLegacy — Net written premiums
$89M-83.9%
Axis Capital Holders logo
AXSReinsurance — Gross premiums written
$1.11B-2.2%
SiriusPoint logo
SPNTReinsurance — Premiums written, gross
$319.2M-10.0%
SiriusPoint logo
SPNTReinsurance — Net premiums written
$281.85M+2.1%
Chubb logo
CBGlobal Reinsurance — Net premiums written
$363M-11.0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenGross.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — gross premiums written.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — gross premiums written?
King Pharmaceuticals (KG) reported legacy reinsurance — gross premiums written of $2.66M in Q1 2026.
What does legacy reinsurance — gross premiums written mean?
Represents the total premiums written by the legacy reinsurance segment before the deduction of reinsurance ceded. This metric measures the top-line volume of business underwritten by the segment and reflects its market reach and underwriting activity.